Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

University Hospital, Strasbourg, France20,000 enrolled

Overview

The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.

Study Type

OBSERVATIONAL

Enrollment

20,000

Conditions

Down Syndrome

Interventions

echographyDEVICE

blood sampleOTHER

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Female \> 18 years old * Pregnant Exclusion Criteria: * Maternal age \< 18 years old, twin pregnancy

Locations (7)

Département de Gynécologie-Obstétrique, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg

Strasbourg, Alsace, France

Service de Gynécologie-Obstétrique, SIHCUS, CMCO

Strasbourg, Alsace, France

Centre Hospitalier

Belfort, France

Centre Mère et Enfant LE PARC, Service de Gynécologie Obstétrique

Colmar, France

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.